Press release
Artificial Blood Market to Reach US$ 7.19 Billion by 2031, Driven by Critical Care Adoption
Artificial Blood Market
Produced through recombinant biochemical techniques or synthetic processes, artificial blood products such as hemoglobin-based oxygen carriers (HBOCs) and perfluorocarbon (PFC) emulsions are increasingly adopted in trauma care, surgeries, neonatal interventions, and organ transplants. North America currently leads in market share due to advanced healthcare infrastructure, while Asia-Pacific is set to record the fastest growth owing to rising trauma incidents, surgical demand, and government-led blood safety initiatives.
Get a Free Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.datamintelligence.com/download-sample/artificial-blood-market?utm_source=OpenPR&utm_campaign=Onkar
Key Highlights from the Report
➤ Artificial blood market to reach US$ 7,194.83 million by 2031 at an 8.7% CAGR.
➤ HBOCs segment leads with 61% share in 2024, used widely in emergency and surgical care.
➤ Human blood-derived substitutes hold 47% share due to high oxygen-carrying efficiency.
➤ Cardiovascular diseases account for 36% of applications, followed by neonatal and transplant care.
➤ North America maintains dominance with 38.65% share supported by advanced infrastructure.
➤ Asia-Pacific set for fastest growth driven by rising surgical procedures and blood supply challenges.
Market Segmentation
By product type, the market is split between HBOCs and PFCs. HBOCs dominate with 61% share due to superior oxygen transport and seamless integration with transfusion protocols, especially for chronic anemia, trauma, and complex surgeries. PFCs, projected to grow fastest at 8.5% CAGR, are gaining traction in trauma units and critical care settings due to advances in synthetic oxygen carrier technology.
By source, human blood-derived substitutes hold 47% share, driven by proven clinical safety and reliability in emergencies. Microorganism-based recombinant hemoglobin and synthetic polymer sources are expected to rise rapidly with bioengineering innovations enabling scalable production.
By application, cardiovascular diseases lead with 36% share, while neonatal and organ transplant segments are among the fastest-growing due to increasing complexity in interventions and awareness of donor blood limitations.
By end-user, hospitals and clinics dominate with 65% share, reflecting reliance on artificial blood in high-demand surgical and trauma care scenarios. Blood banks show strong potential growth (9.5% CAGR) as substitutes help mitigate donor shortages and ensure supply readiness.
Get Customization in the Report as Per Your Business Requirements: https://www.datamintelligence.com/customize/artificial-blood-market?utm_source=OpenPR&utm_campaign=Onkar
Regional Insights
North America leads with 38.65% share in 2024, driven by high adoption rates in cardiac surgeries, oncology, and trauma medicine. The U.S. market benefits from favorable regulatory support, strong R&D investment, and integrated use in emergency care.
Europe shows steady growth through stringent blood safety standards and hospital adoption in Germany, France, and the U.K., particularly for cardiovascular emergencies and oncology.
Asia-Pacific is the fastest-growing regional market, supported by expanding hospital infrastructure, domestic manufacturing capabilities, and increasing government focus on critical care. Japan and China are notable contributors, with Japan emphasizing geriatric care integration and China leading in regional market share due to manufacturing scale and rising surgical volumes.
Market Dynamics
Market Drivers
Global blood shortages and growing demand in critical care settings propel adoption of artificial blood. Clinical integration in trauma, neonatal care, and organ transplants is increasing, supported by longer shelf life and reduced infection risks compared to donor blood.
Market Restraints
High production costs and stringent regulatory approvals slow wider adoption, with extended timelines for product clearance challenging market penetration.
Purchase This Exclusive Report at Just USD 4374 Only: https://www.datamintelligence.com/buy-now-page?report=artificial-blood-market?utm_source=OpenPR&utm_campaign=Onkar
Market Opportunities
Technological innovation in synthetic and recombinant hemoglobin, alongside government-backed blood safety initiatives, opens pathways for expanded clinical applications and improved affordability.
Reasons to Buy the Report
✔ Detailed international market analysis with forecasts through 2031.
✔ Segmentation insights covering product types, sources, applications, and end-users.
✔ Evaluation of regional adoption trends and growth opportunities.
✔ Analysis of regulatory factors shaping market accessibility.
✔ Coverage of key players and latest technological developments.
Frequently Asked Questions (FAQs)
◆ How big is the global artificial blood market in 2023 and 2031?
◆ Who are the key players in the global artificial blood substitutes market?
◆ What is the projected CAGR for the artificial blood market from 2024 to 2031?
◆ Which region leads in artificial blood adoption worldwide?
◆ What product types dominate the global artificial blood market?
Company Insights
Aurum Biosciences (U.K.)
HEMARINA (France)
Hemoglobin Oxygen Therapeutics LLC (U.S.)
KaloCyte, Inc. (U.S.)
SpheriTech Ltd. (U.K.)
Centrum Medyczne VisusMed (Poland)
OPKO Health, Inc. (U.S.)
NuvOx Therapeutics (U.S.)
Prolong Pharmaceuticals, LLC (U.S.)
GC Corp. (South Korea)
NanoBlood LLC (U.S.)
Scarlet Therapeutics Limited (U.S.)
Vivosang (U.S.)
Recent Developments
June 2025: Japanese researchers developed a universal artificial blood product with years-long shelf life, enhancing emergency and remote medical care.
February 2025: North Carolina State University and UNC researchers created synthetic hydrogel-based blood platelets, offering freeze-dry storage and rapid rehydration for trauma and battlefield use.
Conclusio
The global Artificial Blood Market is set for accelerated growth over the next decade as hospitals, trauma centers, and surgical units worldwide integrate substitutes into critical care protocols. With advances in synthetic oxygen carriers, improved stability, and widened clinical applications, artificial blood is becoming a pivotal solution to global blood shortages. North America maintains leadership through advanced infrastructure and strong R&D, while Asia-Pacific's rapid growth reflects increasing healthcare access and manufacturing capacity. As innovation continues to address cost and regulatory challenges, artificial blood will play a transformative role in life-saving medical interventions globally.
Contact Us
Mr. Sai Kiran
DataM Intelligence 4market Research LLP Ground floor
DSL Abacus IT Park, Industrial Development Area
Uppal, Hyderabad, Telangana 500039
USA: +1 877-441-4866
Email: Sai.k@datamintelligence.com
Visit Our Website: https://www.datamintelligence.com
About Us
DataM Intelligence 4Market Research is a comprehensive market intelligence platform offering syndicated and customized reports along with expert consulting across multiple industries, including chemicals, healthcare, agriculture, food & beverages, and more. With extensive experience and a strategy-focused approach, DataM provides businesses and individuals with reliable market insights, statistical forecasts, and personalized research solutions to help them make informed decisions and successfully bring innovations to market.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Artificial Blood Market to Reach US$ 7.19 Billion by 2031, Driven by Critical Care Adoption here
News-ID: 4211428 • Views: …
More Releases from DataM Intelligence 4Market Research LLP
Construction Chemicals Market Set to Hit USD 83.2 Billion by 2031 | BASF, Saint- …
The Global Construction Chemicals Market reached US$ 53.0 billion in 2023 and is expected to reach US$ 83.2 billion by 2031, growing at a CAGR of 5.8% from 2024 to 2031, according to DataM Intelligence.
Construction chemicals are specialty formulations and admixtures used to enhance the performance, durability, and sustainability of concrete, masonry, coatings, waterproofing systems, adhesives & sealants, floorings and other building materials. Demand is being driven by large-scale…
Medical Biosensors Market Size to Reach $12.6 Billion by 2033 Driven by Wearable …
The Global Medical Biosensors Market, valued at US$ 6.09 billion in 2024, is projected to reach US$ 12.60 billion by 2033, expanding at a CAGR of 8.4% during 2025-2033, according to DataM Intelligence. This steady growth is supported by increasing demand for advanced diagnostic tools, real-time monitoring, and technological advancements in nanotechnology and microelectronics.
Biosensors, which combine biological elements with physicochemical detectors, are crucial in patient monitoring, disease diagnosis, and personalized…
Diabetes Drugs Market Size to Reach US$ 141.73 Billion by 2032 Driven by Rising …
The Global Diabetes Drugs Market, valued at US$ 78.11 billion in 2024, is expected to reach US$ 141.73 billion by 2032, growing at a CAGR of 7.8% between 2025 and 2032, according to DataM Intelligence. Diabetes drugs play a critical role in controlling blood glucose levels and preventing serious complications such as cardiovascular disease, kidney failure, nerve damage, and vision problems.
Market growth is underpinned by the rising prevalence of both…
Medical Tourism Market to Reach $230.35 Billion by 2033 Driven by Affordable, Hi …
The Global Medical Tourism Market, valued at US$ 47.09 billion in 2024, is projected to reach US$ 230.35 billion by 2033, growing at a strong CAGR of 19.4% between 2025 and 2033, according to DataM Intelligence. Medical tourism involves traveling abroad to receive medical care that is often more cost-effective, specialized, or of higher quality than what is available domestically. It covers a wide range of services including dental procedures,…
More Releases for Artificial
Artificial Intelligence or Artificial Soul by Denise White
Author Denise White exposes the subtle societal forces shaping young minds and offers profound wisdom to help children develop resilience against artificial influences.
As artificial intelligence continues to permeate every aspect of modern life, from self-driving cars to virtual assistants, a critical question arises: Are we sacrificing our authenticity and human essence for the sake of technological advancement? In her latest book, Guarding the Child's Imagination , author Denise White sheds…
Artificial Neural Network Software Market: Advancements in Artificial Neural Net …
The Report on "Artificial Neural Network Software Market" provides Key Benefits, Market Overview, Regional Analysis, Market Segmentation, Future Trends Upto 2030 by Infinitybusinessinsights.com. The report will assist reader with better understanding and decision making.
Market Growth of Artificial Neural Network Software Market: The artificial neural network software market is experiencing robust growth as organizations across various industries increasingly leverage AI-driven solutions to enhance decision-making, automate processes, and gain actionable insights from…
Global Artificial Intelligence Market, Global Artificial Intelligence Industry, …
Major players in the artificial intelligence market are Google, IBM, Baidu, Microsoft, Apple Inc., Ipsoft, NVIDIA Corporation, Samsung Electronics Co.Ltd, and Micro Strategy Inc.
The Global Artificial Intelligence Market is expected to grow from USD 28.42 billion in 2019 to USD 40.74 billion in 2020 at a compound annual growth rate (CAGR) of 43.39%. The growth is mainly due to the COVID-19 health emergency across the globe that has led to…
Artificial Iris Market - Industry Analysis, Size, Share, Growth, Trends, and For …
The global Artificial Iris Market is anticipated to gain the market worth of US$ 16.28 million by 2025, expanding at a CAGR of 6.39% during the forecast period 2019-2025. The natural pupil controls the amount of light that enters the eye and people with pupil or iris abnormalities may experience glare or haloes in sunlight or bright artificial light. Patients may also feel self-conscious about the appearance of their eyes…
Global Artificial Organs Market Facts, Figures and Analytical Insights, 2018 to …
Artificial Organs Market Introduction
Artificial organ is an engineered device or tissue that is implanted into the human body. These artificial organs replace a natural organ in order to duplicate a specific function so that the patient can return to a normal life. It is a medical device with biochemical or mechanical function such as lung, heart, liver, kidney, or neurosensory organs.
Artificial organs are surgically implanted or are extra…
Artificial Kidney Market Report 2018: Segmentation by Type (Wearable Artificial …
Global Artificial Kidney market research report provides company profile for Medtronic, DaVita, Merit Medical Systems, NIPRO Medical Corporation, Nikkiso, B. Braun Melsungen AG, Kawasumi Laboratories, Fresenius, Baxter, Asahi Kasei Medical, Xcorporeal and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for…
